Q&A Session with the Expert Speakers

Time: 4:30 pm
day: Day One


• Understanding evidence requirements of public vs private insurers
• Clarifying the reimbursement categories within the US market, from drug to psychosocial services, and their impact on DTx development and commercialization
• Developing direct to consumer models: Comparing prescribable to over-the-counter routes for consumer accessibility
• Exploring recent guidelines issued by NICE and Germany, and what these mean for international growth